FIELD: medicine; biology.
SUBSTANCE: invention relates to the field of biology and medicine. Disclosed is use of crystalline lithium ascorbate of general formula LiC6H7O6 as an agent inducing production of interleukin-8.
EFFECT: invention extends the range of inducers of interleukin-8 and can be used in cell biology, experimental medicine, pharmacology.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT WHICH INCREASES ERYTHROCYTE RESISTANCE TO HAEMOLYSIS INDUCED BY ETHANOL | 2018 |
|
RU2699224C1 |
SYNTHETIC ANALOGS OF IL-10 | 1997 |
|
RU2194054C2 |
AGENT OF APOPTOSIS-INDUCTIVE ACTIVITY | 2017 |
|
RU2654711C1 |
CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
METHOD FOR DETECTING PRECANCEROUS CHANGES IN THE MAMMARY GLAND | 2017 |
|
RU2674164C1 |
5-(4-METHANESULPHONYL PHENYL)THIAZOLE DERIVATIVES FOR TREATING ACUTE AND CHRONIC INFLAMMATORY DISEASES | 2009 |
|
RU2495031C2 |
METHOD FOR STIMULATING ENDOGENOUS PRODUCTION OF CYTOKINES AND HEMOPOIETINS | 2012 |
|
RU2498821C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
IMMUNITY INDUCING AGENT | 2009 |
|
RU2511039C2 |
Authors
Dates
2020-01-31—Published
2019-08-07—Filed